These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7803250)

  • 41. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z; Seligsohn U; Zivelin A; Eldor A
    Harefuah; 1995 Jul; 129(1-2):1-5, 80. PubMed ID: 7557699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B; Hillarp A; Berntorp E; Dahlbäck B
    Annu Rev Med; 1997; 48():45-58. PubMed ID: 9046944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.
    Steen M; Norstrøm EA; Tholander AL; Bolton-Maggs PH; Mumford A; McVey JH; Tuddenham EG; Dahlbäck B
    Blood; 2004 May; 103(9):3381-7. PubMed ID: 14695241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein C.
    Williamson D; Brown K; Luddington R; Baglin C; Baglin T
    Blood; 1998 Feb; 91(4):1140-4. PubMed ID: 9454742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No association between thrombosis and factor V gene polymorphisms in Chinese Han population.
    Yanqing H; Fangping C; Qinzhi X; Zaifu J; Guangping W; Xiaoxia Z; Xiaoqun P; Xiaobo
    Thromb Haemost; 2003 Mar; 89(3):446-51. PubMed ID: 12624626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals.
    Zama T; Murata M; Ono F; Watanabe K; Watanabe R; Moriki T; Yokoyama K; Tokuhira M; Ikeda Y
    Int J Hematol; 1996 Dec; 65(1):71-8. PubMed ID: 8990627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
    Zöller B; He X; Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Point mutation G-->A nucleotide 1691 factor V gene as a cause of developing thrombotic complications in a family with plasma resistance to activated protein C].
    Lew Andowski KL; Rozek M; Turowiecka Z; Markiewicz WT; Zawilska K
    Pol Arch Med Wewn; 1996 May; 95(5):464-70. PubMed ID: 8848415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APC resistance: biological basis and acquired influences.
    Castoldi E; Rosing J
    J Thromb Haemost; 2010 Mar; 8(3):445-53. PubMed ID: 20002539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lupus anticoagulant interference in activated protein C resistance testing: in vitro phenomenon or in vivo pathophysiologic effect?
    Shen YM; Cimo ML; Bai Y; Frenkel E; Sarode R
    Clin Appl Thromb Hemost; 2011; 17(6):E190-5. PubMed ID: 21406411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombosis in otherwise well children with the factor V Leiden mutation.
    Sifontes MT; Nuss R; Jacobson LJ; Griffin JH; Manco-Johnson MJ
    J Pediatr; 1996 Mar; 128(3):324-8. PubMed ID: 8774498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
    Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
    J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.
    Simioni P; Scarano L; Gavasso S; Sardella C; Girolami B; Scudeller A; Girolami A
    Br J Haematol; 1996 Feb; 92(2):435-41. PubMed ID: 8603014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombophilia as a multigenic disease.
    Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
    Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients].
    Hakala L; Vahtera E; Krusius T; Rasi V
    Duodecim; 1995; 111(22):2143-51. PubMed ID: 9841174
    [No Abstract]   [Full Text] [Related]  

  • 58. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
    Koeleman BP; van Rumpt D; Hamulyák K; Reitsma PH; Bertina RM
    Thromb Haemost; 1995 Aug; 74(2):580-3. PubMed ID: 8584987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden.
    Zehnder JL; Benson RC
    Am J Clin Pathol; 1996 Jul; 106(1):107-11. PubMed ID: 8701918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular detection of a common mutation in coagulation factor V causing thrombosis via hereditary resistance to activated protein C.
    Liu XY; Nelson D; Grant C; Morthland V; Goodnight SH; Press RD
    Diagn Mol Pathol; 1995 Sep; 4(3):191-7. PubMed ID: 7493138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.